Search the Archive

Commercial: HIV / Kisqali #1250881

CBS Evening News for Tuesday, Feb 25, 2020
View other clips in this broadcast →

Material supplied by VTNA may be used for educational analysis or research only. Any editing, reproduction, publication, rebroadcast, public showing or public display may be prohibited by copyright laws.

We are the thrivers. Women with metastatic breast cancer standing in the struggle, hustling through the herd, asking for science, not sorries. Our time for more time has come. Living longer is possible and proven in women taking Kisqali plus fulvestrant or a nonsteroidal aromatase inhibitor. Kisqali is the only treatment in its class with proven overall survival results in two clinical trials. Helping women live longer with HIV positive her 2 negative metastatic breast cancer. Kisqali was also s...

Note to sponsor members: The Vanderbilt Television News Archive video player requires a modern operating system and browser to work properly. If you are experiencing playback problems, check the minimum requirements and adjust your setup accordingly. After adjustments, if you continue to experience problems, please contact us.

Welcome! Above is the abstract of the item that you're interested in viewing from the Vanderbilt Television News Archive's collection. You have three options if you'd like to view this item:

  • You may request a loan of this video by registering on our website and placing an order.
  • You may visit the Television News Archive on the Vanderbilt campus to view on-site from the Archive's collection.
  • If you are associated with a college or university, you may ask your library if they would like to become a sponsor, which would give students and faculty at your institution the ability to view items from our collection.

If you believe that you are associated with a sponsoring college or university and have received this message in error, please let us know.